Healthcare & Life Sciences
T3 Pharmaceuticals AG
Germany
series-c-plus
series-c-plus
Stage
1
Investors
About
T3 Pharmaceuticals AG develops novel precision oncology drugs focused on targeted therapies to treat cancer by modulating specific molecular pathways.
Explore T3 Pharmaceuticals AG's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.